Journal article icon

Journal article

Rituximab in the treatment of rheumatoid arthritis.

Abstract:

Rheumatoid arthritis is a chronic, disabling condition and the most common form of inflammatory arthritis affecting approximately 1% of the population. The outlook has improved considerably over the last decade with the recognition that better outcomes accompany early and optimal suppression of synovitis. In some patients, this can be achieved with conventional, oral disease-modifying anti-rheumatic drugs. For those with more severe disease, the introduction of biologic therapies targeting th...

Expand abstract

Actions


Access Document


Publisher copy:
10.1586/1744666x.3.1.17

Authors


More by this author
Institution:
University of Oxford
Department:
Oxford, MSD, NDORMS
Role:
Author
Journal:
Expert review of clinical immunology
Volume:
3
Issue:
1
Pages:
17-26
Publication date:
2007-01-05
DOI:
EISSN:
1744-8409
ISSN:
1744-666X
URN:
uuid:72ac70a6-2617-4d12-849a-343d0520ce85
Source identifiers:
227469
Local pid:
pubs:227469
Language:
English

Terms of use


Metrics


Views and Downloads






If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP